List of companies in Eventide Asset Management's investment portfolio
Name | Description | Industry | Official Website | Location | ||
|---|---|---|---|---|---|---|
Magenta Therapeutics is a biotechnology company using stem cells to develop cellular therapies for immune and blood-based diseases. | ||||||
Karuna Therapeutics is a schizophrenia treatment founded in 2009 by Andrew Miller. | ||||||
Pliant Therapeutics is a clinical-stage biopharmaceutical company developing treatments for fibrotic diseases with a focus on fibrotic tissue-specific inhibition of integrins and the TGF-β pathway. | ||||||
Developing gene therapies to potentially cure rare diseases. | ||||||
Goldfinch Biopharma is a Cambridge, Massachusetts-based therapeutics company focused on discovering and developing precision therapies for patients with kidney disease. | ||||||
Freeline Therapeutics Limited is a Stevenage, England-based biotechnology company developing liver directed gene therapies for a range of diseases. | ||||||
Casma Therapeutics is a company that has a research community and uses its understanding of research to develop novel therapeutics to capture disease causing targets. | ||||||
Small molecule compounds that act by unlocking protein-protein interfaces | ||||||
Small Molecules Acting on Stem Cells. Biosplice Therapeutics is in the medical research and development for tissue-level regeneration. | ||||||
Goldfinch Bio is a Cambridge, Massachusetts-based biotechnology company. | ||||||
Bionic Pancreas | ||||||
Turnstone Biologics is an oncolytic viral immunotherapy founded in 2015. | ||||||
PreciseDx is the only Cancer Risk Stratification company to provide patient-specific risk information through the analysis of morphology. | ||||||
Kojin Therapeutics is developing transformative medicines based on a groundbreaking approach to ferroptosis and cell state biology. |
